Dr. Abraham Morgentaler, an Associate Clinical Professor of Urology at Harvard Medical School and affiliated with Beth Israel Deaconess Medical Center, in Boston, MA, along with his coauthors, explore and clarify in the February 2015 issue of Mayo Clinic Proceedings, the value of testosterone therapy in men, and in particular the issue of cardiovascular risk.
Source: YouTube
From evidence to practice: Dr. Makarov discusses implementation science in urology
July 25th 2024“What our major contribution is, I think as urologists doing implementation science, is determining the important questions, which we are particularly well-suited to do because we're taking care of the patients,” says Danil V. Makarov, MD, MHS.